InvestorsHub Logo
Followers 139
Posts 23307
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Wednesday, 02/10/2021 9:21:15 PM

Wednesday, February 10, 2021 9:21:15 PM

Post# of 403174
The company (ticker: GILD) said it expected to report 2020 sales of remdesivir, which is sold under the name Veklury, of between $2.8 billion and $2.83 billion.

https://www.barrons.com/articles/gilead-says-sales-of-covid-19-antiviral-beat-expectations-as-pandemic-worsened-51610378488

combination of brilacidin with remdesivir at 10µM and 2.5µM concentrations, respectively, reduced the viral infectious titer by >99%, thus providing a highly effective inhibition profile (Figure 5B) and achieving greater inhibition than with either compound alone. This synergistic inhibition continued to remain higher than 99% when the concentrations of both compounds were equal (2.5µM each) (Figure 5C


https://www.biorxiv.org/content/10.1101/2020.10.29.352450v1.full

Good luck and GOD bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News